Patents by Inventor David Lafargue

David Lafargue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11391203
    Abstract: The invention relates to an aircraft propulsion system, comprising a main transmission unit (12) and at least two turbojet engines connected to the main transmission unit (12), respectively a first turbojet engine (14a) and a second turbojet engine (14b), each turbojet engine comprising a free turbine (24a, 24b), characterized in that the first turbojet engine (14a) comprises a heat exchanger (30) configured to recover some of the thermal energy from the exhaust gas at the outlet of the free turbine, and in that the propulsion system comprises at least one computer (28a, 28b) configured to control the two turbojet engines and to limit the acceleration and the deceleration of the first turbojet engine (14a) when neither of the turbojet engines is broken down, in order to limit the reactor power transients at the heat exchanger (30).
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: July 19, 2022
    Assignee: SAFRAN HELICOPTER ENGINES
    Inventors: Olivier Audrey David Lafargue, Thomas Klonowski, Antoine Pascal Moutaux
  • Patent number: 9856221
    Abstract: Ivabradine hemipamoate of formula (I): and its hydrates. Medicinal products containing the same which are useful in the treatment or prevention of the various clinical situations of myocardial ischaemia such as angina pectoris, myocardial infarction and the associated rhythm disturbances, as well as in the various pathologies involving rhythm disturbances, especially supraventricular rhythm disturbances, and in systolic or diastolic heart failure.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: January 2, 2018
    Assignee: LES LABORATOIRES SERVIER
    Inventors: Michael Lynch, Patrick Cointepas, David Lafargue, Gilles Briault
  • Publication number: 20170050932
    Abstract: Ivabradine hemipamoate of formula (1): and its hydrates. Medicinal products containing the same which are useful in the treatment or prevention of the various clinical situations of myocardial ischaemia such as angina pectoris, myocardial infarction and the associated rhythm disturbances, as well as in the various pathologies involving rhythm disturbances, especially supraventricular rhythm disturbances, and in systolic or diastolic heart failure.
    Type: Application
    Filed: May 6, 2015
    Publication date: February 23, 2017
    Inventors: Michael LYNCH, Patrick COINTEPAS, David LAFARGUE, Gilles BRIAULT
  • Publication number: 20150238614
    Abstract: Stabilised amorphous form of the compound of formula (I): Medicaments
    Type: Application
    Filed: September 11, 2013
    Publication date: August 27, 2015
    Inventors: David Lafargue, Michael Lynch, Cécile Poirier, Philippe Letellier, Jean-Manuel Pean, Ying Luo, Hanbin Shan, Yuhui Shen